Sangamo Therapeutics (SGMOQ) Non Operating Income (2010 - 2012)
Sangamo Therapeutics (SGMOQ) posted Non Operating Income of -$109000.0 for Q4 2012, down 1008.33% on a QoQ basis from $12000.0 in Q3 2012, and down 1916.67% year-over-year from $6000.0 in Q1 2012.
Analysis
Sangamo Therapeutics (SGMOQ) Non Operating Income (2010 - 2012) Analysis & Trends
Sangamo Therapeutics has reported Non Operating Income for 3 years, with the latest figure at -$109000.0 in Q4 2012.
- On a quarterly basis, Non Operating Income fell 1916.67% year-over-year to -$109000.0 in Q4 2012; TTM through Dec 2012 was -$66000.0, a 192.96% decrease from a year earlier, with the FY2014 full-year figure at $364000.0, up 343.9% from the prior year.
- Non Operating Income was -$109000.0 for Q4 2012 at Sangamo Therapeutics, down from $12000.0 in the prior quarter.
- The five-year high for Non Operating Income was $23000.0 in Q1 2011, with the low at -$109000.0 in Q4 2012.
- Average Non Operating Income over 3 years is $4200.0, with a median of $16500.0 recorded in 2010.
- The sharpest annual moves came in 2011 and 2012: Non Operating Income changed 0.0% in 2011, then plunged 1916.67% in 2012.
- Over 3 years, Non Operating Income stood at $17000.0 in 2010, then plunged by 64.71% to $6000.0 in 2011, then slumped by 1916.67% to -$109000.0 in 2012.
- The last three Non Operating Income figures came in at -$109000.0 (Q4 2012), $12000.0 (Q3 2012), and $16000.0 (Q2 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.09 Bn | 9.24 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.22 Bn | 5.22 Bn | - | 27.08 Mn |
| 3 | Iovance Biotherapeutics | 3.90 Bn | 3.60 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.67 Bn | 2.70 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.10 Bn | 3.10 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.69 Bn | 2.69 Bn | - | 3.88 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | -2.57 Mn |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn | -15.04 Mn |
| 9 | Vericel | 1.99 Bn | 1.82 Bn | 56.40 Mn | 1.77 Mn |
| 10 | Sangamo Therapeutics | 43.29 Mn | 22.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | -109,000.00 |
| Sep 30, 2012 | 12,000.00 |
| Jun 30, 2012 | 16,000.00 |
| Mar 31, 2012 | 15,000.00 |
| Dec 31, 2011 | 6,000.00 |
| Sep 30, 2011 | 20,000.00 |
| Jun 30, 2011 | 22,000.00 |
| Mar 31, 2011 | 23,000.00 |
| Dec 31, 2010 | 17,000.00 |
| Sep 30, 2010 | 20,000.00 |